antiparkinson agents

antiparkinson agents

agents used to control symptoms of Parkinson's disease, i.e. dopaminergic agents (e.g. levodopa, amantadine, bromocriptine, pramipexole, selegiline) and antimuscarinic agents (e.g. orphenadrine [Disipal], procyclidine [Kemadrin])
References in periodicals archive ?
Data about LUTS, number of comorbid diagnoses, number of antiparkinson agents, number of non-PD medications, PD duration, diagnosis of major depression, diagnosis of anxiety, and demographic characteristics were obtained from the PADRECC Admission Questionnaire.
Other commonly used medications that have been identified as increasing the risk of UI include antihistamines, antispasmodics, antiparkinson agents, angiotensin-convertingenzyme (ACE) inhibitors, calcium channel blockers, and alpha antagonists (Thompson & Smith, 2002).
Table Differential diagnosis for chorea Genetic Huntington's disease, benign hereditary chorea, neuroacanthocytosis, dentatorubral-pallidoluysian atrophy, Wilson's disease, spinocerebellar ataxia, Friedreich's ataxia Rheumatic disorders Sydenham's chorea, chorea gravidarum Drug-induced/toxicity Neuroleptic drugs, steroids, anticonvulsants, antiparkinson agents, stimulants (amphetamines, cocaine), lithium, dopamine agonists Systemic disorders Systemic lupus erythematosus, thyrotoxicosis, polycythemia vera, hyperglycemia, AIDS, paraneoplastic syndrome Vascular/trauma Cerebral hemorrhage, vasculitis, stroke, antiphospholipid antibody syndrome AIDS: acquired immune deficiency syndrome Source: References 1,2
gabepentin, 1704 68 oxcarbazepine, topiramate) CN500 Antiparkinson Agents (e.